在肝硬化患者中,饮食习惯与萨尔科佩尼亚之间的关联
Mirabela-Madalina Topan1, Ioan Sporea1,2, Mirela Dănilă1,2
1Department of Gastroenterology and Hepatology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Journal of clinical medicine
|July 29, 2023
概括
肝硬化患者经常患有缩症和缩性肥胖症. 他们的饮食质量不佳意味着能量和蛋白质摄入量低,不足于建议.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 营养科学 营养科学
- 老年病的医生 老年病的医生
背景情况:
- 缩症和缩性肥胖症在肝硬化患者中很常见.
- 饮食模式显著影响这些疾病的发展.
- 了解饮食充足对于治疗肝硬化患者至关重要.
研究的目的:
- 为了评估肝硬化患者的饮食摄入量充足度.
- 评估营养状况及其与肉症和肉性肥胖症的关系.
主要方法:
- 201名肝硬化患者使用EWGSOP2标准进行了分析.
- 评估了营养状况,将患者分为非sarcopenic,sarcopenic和sarcopenic肥胖症组.
- 饮食摄入量在一个月内在三个不连续的24小时期间进行了评估.
主要成果:
- 萨科佩尼亚的患病率为57.2%,而萨科佩尼性肥胖率为25.3%.
- 麻症患者的能量摄入量低于推.
- 在sarcopenic (0.85 g/kg BW) 和sarcopenic肥胖 (0.77 g/kg BW) 两组中,蛋白质摄入量都很低.
结论:
- 肝硬化患者的饮食质量通常很差.
- 能量和蛋白质消耗低于建议水平,特别是在肉患者中.
- 可能需要进行营养干预,以解决这一群体的饮食摄入不足问题.
相关概念视频
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Dietary Connections
51.2K
In biological systems, most metabolic pathways are interconnected. The cellular respiration processes that convert glucose to ATP—such as glycolysis, pyruvate oxidation, and the citric acid cycle—tie into those that break down other organic compounds. As a result, various foods—from apples to cheese to guacamole—end up as ATP. In addition to carbohydrates, food also contains proteins and lipids—such as cholesterol and fats. All of these organic compounds are used...
51.2K
Liver Regeneration
3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
Diseases of the Liver and Gallbladder
634
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
634
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K


